A rare case of bilateral cystoid macular oedema associated with decompensated Henoch-Schonlein purpura-related nephropathy

2015 ◽  
Vol 44 (3) ◽  
pp. 209-212 ◽  
Author(s):  
Rajan S Patheja ◽  
Aaron Chidgey
2010 ◽  
Vol 40 (11) ◽  
pp. 795-796 ◽  
Author(s):  
E. Fiaux ◽  
Y. Benhamou ◽  
N. Cailleux ◽  
H. Levesque

2020 ◽  
Vol 11 (6) ◽  
pp. 160-165
Author(s):  
Mujtaba Mohamed ◽  
Mohammed Shariff ◽  
Alsadiq Al Hillan ◽  
Rani Al Haj ◽  
Christian Kaunzinger ◽  
...  

2015 ◽  
Vol 4 (4) ◽  
pp. 81
Author(s):  
Amieleena Chhabra ◽  
Taoas Baikar ◽  
Vivek Dewan ◽  
tribhuvan Yadav

2012 ◽  
Vol 15 (4) ◽  
pp. 307 ◽  
Author(s):  
Kaushik Ghosh ◽  
JyotiTanmay Sau ◽  
Atri Chatterjee ◽  
Sandip Dey

Author(s):  
Pardha Sivakoti ◽  
Saraswathi Banavath ◽  
Alekya Vulpala ◽  
Monica Rayapu ◽  
Bhagyaraj Pulavarthi ◽  
...  

Author(s):  
Srujith Chandrakanti ◽  
Oshin Mantro ◽  
Jagadeesan Mohanan ◽  
Mervin Kayipirambil Soman ◽  
Prasanna Karthik Suthakaran ◽  
...  

  Henoch–Schonlein purpura (HSP) is a common leukocytoclastic vasculitis seen in children. However, it is uncommon in adults. HSP is characterized by the classic tetrad of non-thrombocytopenic palpable purpura, arthritis or arthralgias, gastrointestinal, and renal involvement. We report a rare case of adult onset HSP with multi-organ involvement. Early recognition of multi-organ involvement is very important, especially in adults.


Author(s):  
Abdelhamid Naitlho ◽  
Wahib Lahlou ◽  
Abderrahim Bourial ◽  
Hamza Rais ◽  
Nabil Ismaili ◽  
...  

AbstractIn the COVID-19 pandemic era, anti-SARS-CoV-2 vaccination is considered to be the most efficient way to overtake the COVID-19 scourge. Like all medicines, vaccines are not devoid of risks and can in rare cases cause some various side effects. The objective of this case report is to highlight this unusual presentation of Henoch-Schönlein purpura following an anti-COVID-19 vaccination in a 62-year-old adult. The 62-year-old patient admitted to the emergency room for a petechial purpuric rash, sloping, occurring within hours, involving both legs and ascending. The clinical signs also included polyarthralgia and hematuria. Reported in the history the notion of an anti-COVID-19 vaccination 8 days prior to the onset of symptomatology. In the case of our patient, we retain the diagnosis of rheumatoid purpura based on the EULAR/PRINTO/PReS diagnostic criteria. Corticosteroid therapy (prednisone) was started, resulting to a rapid regression of clinical and laboratory symptoms, few days after the treatment. Patient was asymptomatic on subsequent visits. The low number of published cases of post-vaccine vasculitis does not question the safety of vaccines, but knowledge of such complications deserves to be known in order to avoid new immunizations that could have more serious consequences, and to avoid aggravating or reactivating a pre-existing vasculitis.


Sign in / Sign up

Export Citation Format

Share Document